A*STAR disarms pathway protecting lung cancer cells

The discovery addresses resistance amongst patients after one to two years of treatment.

Researchers at Agency for Science, Technology and Research (A*STAR) have identified a cellular pathway that allows EGFR-mutant lung cancer cells to survive treatment.

This finding could influence future drug development and treatment strategies.

The study, published in Science Advances, shows that high energy levels inside cancer cells activate a signalling process that protects mutant EGFR proteins from breaking down after targeted therapy.

EGFR-targeted drugs are widely used to treat lung adenocarcinoma, particularly in Asia, but most patients develop resistance within one to two years.

In laboratory models, blocking this pathway led to the breakdown of mutant EGFR proteins and reduced tumour growth.

The results point to a potential new drug target that could be used alongside existing therapies to delay resistance.

Lung cancer remains the leading cause of cancer deaths worldwide, with EGFR mutations more common in East Asian patients.

A NOTE FROM SINGAPORE BUSINESS REVIEW

If you've been wondering whether SBR could work for your company — yes, probably.

A lot of the companies we partner with started as readers. They'd been following our coverage for a while, saw their own customers and competitors in it, and eventually asked the obvious question: could we do something with you? The answer is usually yes. The shape of it depends on what you're trying to do.

The options are broader than most people assume — thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. Some partners use one channel; most use a mix. We figure out the right combination by starting with your brief, not with our rate card.

So if the question has been on your mind, here's the easy way to ask it.

We'll tell you honestly whether we can help, and how. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia